Lewis Kopenhafer, BA

Cerner Enviza

Disclosure(s): No financial relationships to disclose

Poster(s):

• 117 - Preferences for Clostridioides difficile Vaccine Attributes Among Adults in the United States
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET